Bionomics Limited
64Patents
57Active
64Granted
53Portfolio score
Filing activity: Jun 20, 2001 → Apr 20, 2022 · 14 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6908546B2 | Apparatus and method for producing purified water having microbiological purity | Performing Operations; Transporting | 62 | Expired |
| US7282336B2 | Method of diagnosing epilepsy | Human Necessities | 14 | Expired |
| US8293737B2 | Anxiolytic compounds | Human Necessities | 10 | Active |
| US7078515B2 | Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus | Human Necessities | 10 | Expired |
| US8551990B2 | Anxiolytic compounds | Human Necessities | 7 | Active |
| US8614212B2 | Anxiolytic compounds | Human Necessities | 7 | Active |
| US8680135B2 | Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors | Chemistry; Metallurgy | 6 | Active |
| US8906912B2 | Anxiolytic compounds | Human Necessities | 5 | Active |
| US9220774B2 | Methods of treating cancer by administering anti-GPR49 antibodies | Chemistry; Metallurgy | 4 | Active |
| US9133188B2 | Methods for preparing naphthyridines | Chemistry; Metallurgy | 4 | Active |
| US9221906B2 | Methods of inhibiting solid tumor growth by administering GPR49 antibodies | Chemistry; Metallurgy | 4 | Active |
| US9221907B2 | Anti-GPR49 monoclonal antibodies | Chemistry; Metallurgy | 4 | Active |
| US9023848B2 | Small-molecules as therapeutics | Chemistry; Metallurgy | 4 | Active |
| US9546214B2 | Humanized antibodies that bind LGR5 | Chemistry; Metallurgy | 4 | Active |
| US9062013B2 | Positive allosteric modulators of the α7 nicotinic acetylcholine receptor and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9006284B2 | Combination therapy for treating proliferative diseases | Human Necessities | 3 | Active |
| US9573945B2 | Anxiolytic compounds | Human Necessities | 3 | Active |
| US7709225B2 | Nucleic acids encoding mutations in sodium channels related to epilepsy | Chemistry; Metallurgy | 3 | Active |
| US8198466B2 | Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7723027B2 | Methods for the diagnosis and treatment of epilepsy | Chemistry; Metallurgy | 2 | Expired |
| US9631024B2 | Antibodies that bind LGR4, their use in inhibiting neoplastic cells and in treating tumors | Chemistry; Metallurgy | 2 | Active |
| US8557982B2 | Tubulin polymerisation inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10954231B2 | Anxiolytic compounds | Human Necessities | 1 | Active |
| US7083927B2 | Gene BN01 mapping to chromosome 16q24.3 | Human Necessities | 1 | Expired |
| US10233181B2 | Anxiolytic compounds | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.